On Tuesday, Dynavax Technologies Corp (NASDAQ: DVAX) opened at On Tuesday, remained unchanged from the last session, before settling in for the closing price of $12.48. Price fluctuations for DVAX have ranged from $9.74 to $14.41 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 217.13% annually for the last half of the decade. Company’s average yearly earnings per share was noted 507.80% at the time writing. With a float of $130.92 million, this company’s outstanding shares have now reached $131.34 million.
In an organization with 408 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 82.85%, operating margin of -3.42%, and the pretax margin is 9.29%.
Dynavax Technologies Corp (DVAX) Insider Updates
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Dynavax Technologies Corp is 0.41%, while institutional ownership is 103.93%. The most recent insider transaction that took place on May 31 ’24, was worth 43,127. In this transaction Director of this company sold 3,615 shares at a rate of $11.93, taking the stock ownership to the 36,905 shares. Before that another transaction happened on Mar 01 ’24, when Company’s Chief Accounting Officer sold 20,526 for $12.78, making the entire transaction worth $262,322. This insider now owns 0 shares in total.
Dynavax Technologies Corp (DVAX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 507.80% per share during the next fiscal year.
Dynavax Technologies Corp (NASDAQ: DVAX) Trading Performance Indicators
Check out the current performance indicators for Dynavax Technologies Corp (DVAX). In the past quarter, the stock posted a quick ratio of 12.34. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.29. Likewise, its price to free cash flow for the trailing twelve months is 72.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.13, a number that is poised to hit 0.04 in the next quarter and is forecasted to reach 0.27 in one year’s time.
Technical Analysis of Dynavax Technologies Corp (DVAX)
Let’s dig in a bit further. During the last 5-days, its volume was 2.39 million. That was better than the volume of 2.09 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 40.11%. Additionally, its Average True Range was 0.37.
During the past 100 days, Dynavax Technologies Corp’s (DVAX) raw stochastic average was set at 62.60%, which indicates a significant increase from 40.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 14.79% in the past 14 days, which was lower than the 32.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.69, while its 200-day Moving Average is $11.63. However, in the short run, Dynavax Technologies Corp’s stock first resistance to watch stands at $12.71. Second resistance stands at $12.94. The third major resistance level sits at $13.14. If the price goes on to break the first support level at $12.28, it is likely to go to the next support level at $12.08. Assuming the price breaks the second support level, the third support level stands at $11.85.
Dynavax Technologies Corp (NASDAQ: DVAX) Key Stats
There are currently 131,455K shares outstanding in the company with a market cap of 1.64 billion. Presently, the company’s annual sales total 232,280 K according to its annual income of -6,390 K. Last quarter, the company’s sales amounted to 80,630 K and its income totaled 17,590 K.
